fbpx
Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK FISH
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.
Featured Video Play Icon

Periodic IBV PCR testing is key to ensuring vaccination efficacy

Complexes should regularly evaluate the infectious bronchitis viruses (IBV) prevalent on their farms to help determine which vaccines can provide the best protection possible.

IB is primarily an upper respiratory tract disease that is most commonly associated with respiratory problems, but it can cause other issues like egg drop, for example, in laying hens.

There are several strains of IBV, and they are typically named after the region where they were first discovered.

A single vaccine tends to target a particular strain, though they can give cross-protection when given in combination, and are usually administered as a spray in broiler hatcheries.

In order to best protect birds, it is important to choose a vaccine, or combination of vaccines, based on the prevalence of different strains in the area and on the farm itself, Kalen Cookson, DVM, Zoetis director of clinical research, told Poultry Health Today.

“Luckily, we have more tools available to us now than we ever had. So we’ve got traditional virus isolation,” he said. “[But more often] today, people are using direct PCR (polymerase chain reaction) to define what their birds are getting exposed to. That’s been a real asset to the industry.

“And so basically people can do surveys at strategic times of the year, usually before the next winter season, to get an idea of what’s in general circulation in their birds.”

Cookson said that the DMV/1639 strain had established itself across much of the “broiler belt” of the US — broadly speaking, the agricultural eastern half of the country.

But there were also other virus strains in circulation, such as Georgia 98 or Georgia 13.

Developing a vaccination plan to best cover each farm is therefore important, Cookson said. “You want to make sure the most prevalent strains that your birds are being exposed to are being addressed in your vaccine program.

“Based on that information, you’ll come up with usually two or three different serotypes that you’ll have in your program. And it may vary by season, as well.”

A Massachusetts vaccine is often a good starting point, Cookson explained, before others are considered based on the environment.

“[With Massachusetts] there’s not a lot of ambiguity in the bird’s immune response, so they recognize that serotype very readily.

“They can respond to it very well and consistently. You can get good take with the vaccine and you get good clearance, which is usually a very good thing.”

The work that Cookson presented at the 2020 American Association of Avian Pathologists’ meeting looked at how combinations of different vaccine strains could offer IBV cross-protection. In particular, it considered how to confer protection against DMV/1639.

It was the first time that all possible combinations of Massachusetts, GA98 and GA08 had been compared to examine cross-protection against DMV/1639. While bivalent combinations, especially Mass + GA08, gave decent cross protection against a very strong DMV/1639 challenge, the trivalent application proved most successful.

“Compared to those bivalent combinations, it was head and shoulders more protective on both indices — on both histological protection of the tracheas, and on shutting down viral infections and shedding in the tracheas,” he said.

“So that was the other major message of that study — the trivalent combination,” he added.

“So, if you’re in a really high-challenge 1639 environment — especially in the wintertime when everything gets concentrated more, less ventilation — the trivalent could be the better alternative, especially if you’re on, say, a Mass-GA08 program and you’re still having a little bit of challenge that it’s not addressing.”

 

 

 

 

 


All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.

©2021 Zoetis Services LLC.               All rights reserved.              BIO-00318

 

Share It
Complexes should regularly evaluate the infectious bronchitis viruses (IBV) prevalent on their farms to help determine which vaccines can provide the best protection possible.

Click an icon to share this information with your industry contacts.



Posted on September 9, 2021

tags: , , , ,
RELATED NEWS
  • Poor IBV vaccine performance in broiler study underlines need for surveillance

    A whole-complex study of broiler breeders in Georgia found underwhelming infectious bronchitis vaccine performance – but with better surveillance and protocols, outcomes could be improved.

  • Poultry industry can learn from COVID-19

    Biosecurity is not sufficient to control avian coronaviruses like infectious bronchitis in commercial poultry, no matter how good it is, said Mark Jackwood, PhD, a molecular virologist and professor of avian medicine at the University of Georgia.

  • California surveillance reveals genetic and seasonal changes in infectious bronchitis virus

    Genotypes of infectious bronchitis virus (IBV) found in California between 2012 and 2020 have seen a “major shift,” according to a study investigating patterns of IBV in the state.

  • ‘Reverse genetics’ may offer new IBV vaccine targets

    Researchers at The Pirbright Institute in the UK report that a recent study provides evidence that mutations in the genetic code for non-structural proteins “offer a promising way” to make vaccines against infectious bronchitis virus (IBV) safer.




You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.